Management of gastrointestinal adverse events induced by immune-checkpoint inhibitors

Chronic Dis Transl Med. 2018 Mar 13;4(1):1-7. doi: 10.1016/j.cdtm.2017.12.001. eCollection 2018 Mar.

Authors

Zheng-Hang Wang¹, Lin Shen¹

Affiliation

¹ Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China.

No abstract available

Keywords: Gastrointestinal tract; Immune-checkpoint inhibitors; Management; Risk factor; Treatment-related adverse event.

Publication types

Review